Welcome to our dedicated page for ReposiTrak SEC filings (Ticker: TRAK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ReposiTrak's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ReposiTrak's regulatory disclosures and financial reporting.
ReposiTrak, Inc. director Robert Allen reported receiving 1,265 shares of common stock on 11/05/2025. These shares were issued instead of cash payments for his service on the company’s Board of Directors for the quarter ended September 30, 2025.
After this transaction, he beneficially owned 199,147 shares of common stock directly, 587,476 shares indirectly through a trust, 2,775 shares indirectly through his spouse, and 39,704 shares of Series B preferred stock directly.
ReposiTrak, Inc. chief executive officer, director and 10% owner Randall K. Fields reported small insider stock sales executed under a Rule 10b5-1 trading plan. On 12/22/2025, an affiliated entity, RK Fields Charitable 2022, LLC, sold 3,000 shares of common stock at a weighted average price of $13.3687 per share. On 12/23/2025, the same entity sold an additional 4,500 shares at a weighted average price of $13.2618 per share. The filing explains that the trading plan was adopted by Fields, in his capacity as trustee of a charitable remainder unitrust, to help meet his charitable commitments. After these sales, Fields continues to beneficially own 3,483,955 shares of common stock directly, plus additional indirect holdings through family and affiliated entities.
TraK (TRAK) insider plans to sell common stock under Rule 144. A notice was filed for the proposed sale of 18,906 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $248,878.58, on or about 12/23/2025 on the NYSE. The issuer has 18,288,455 shares of this class outstanding. The shares to be sold were acquired between 2013 and 2015, mostly as restricted stock vesting under a registered plan in exchange for services, plus an open market purchase for cash. Over the past three months, the same seller disposed of 1,641 common shares for gross proceeds of $21,658.08. The seller represents that he is not aware of undisclosed material adverse information about the issuer.
A shareholder of TRAK has filed a notice of proposed sale of common stock under Rule 144. The filing covers 1,641 common shares, with an aggregate market value of $21,658.08, to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of 12/22/2025. The shares are part of a total of 18,288,455 shares of this class outstanding. The seller originally acquired these shares on 09/19/2013 in an open market purchase from the issuer, paid in cash.
ReposiTrak, Inc. disclosed that its board has declared a quarterly cash dividend of $0.02 per share, which equates to $0.08 per share on an annual basis, on its common stock. The dividend is scheduled to be paid on or about February 13, 2026 to stockholders who are on record as of December 31, 2025. The company furnished this information through a press release attached as an exhibit, emphasizing that it is being provided for informational purposes and is not treated as filed for liability purposes under securities laws.
ReposiTrak, Inc. reported that CEO, director and 10% owner Randall K. Fields sold 7,500 shares of common stock on 12/16/2025 at a weighted average price of $13.2977, coded as an "S" sale transaction.
The sale occurred automatically under a Rule 10b5-1 trading plan adopted by Fields in his capacity as trustee of the 2022 RK Fields Charitable Remainder Unitrust, the managing member of RK Fields Charitable 2022, LLC, and was established to help meet some of his charitable commitments.
After this transaction, Fields beneficially owned 3,483,955 shares of common stock directly, 175,000 shares of common stock indirectly through RK Fields Charitable 2022, LLC, 615,260 common and 229,262 Series B preferred shares through Riverview Financial Corp, 30,667 common and 5,320 Series B preferred shares through his spouse, and 333,643 common shares through Fields Management, Inc.
ReposiTrak, Inc. chairman and chief executive officer Randall K. Fields, who is also a director and 10% owner, reported a series of automatic sales of ReposiTrak common stock made by RK Fields Charitable 2022, LLC under a pre-arranged Rule 10b5-1 trading plan.
The LLC sold 4,453 shares on 12/03/2025 at a weighted average price of $13.4023, 3,000 shares on 12/08/2025 at $13.7212, 2,500 shares on 12/09/2025 at $13.6363, and 2,000 shares on 12/10/2025 at $13.6991, all coded as open-market sales. The prices reflect multiple trades within disclosed price ranges on each day.
Following these transactions, RK Fields Charitable 2022, LLC held 182,500 shares of ReposiTrak common stock. Fields also reported additional holdings, including 3,483,955 shares of common stock held directly and various indirect positions through entities such as Riverview Financial Corp., his spouse, and Fields Management, Inc., as well as related preferred stock holdings.
ReposiTrak, Inc. announced that its Board of Directors has approved a new Rule 10b5-1 share repurchase program authorizing the company to buy back up to $2 million of its common stock. This automated plan operates under the company’s previously approved overall share repurchase authorization of up to $21 million, of which $7.6 million remained available to repurchase as of December 1, 2025. The update was disclosed in a current report and accompanied by a press release filed as an exhibit.
ReposiTrak, Inc.’s chief executive officer, director and 10% owner Randall K. Fields reported small open-market sales of the company’s common stock. On 12/01/2025, an affiliated entity, RK Fields Charitable 2022, LLC, sold 2,000 shares at a weighted average price of $13.3836. On 12/02/2025, the same entity sold 1,047 shares at a weighted average price of $13.0045. Both transactions occurred under a pre-arranged Rule 10b5-1 trading plan designed to help Fields meet charitable commitments through the 2022 RK Fields Charitable Remainder Unitrust. After these sales, he reports indirect ownership of 194,453 shares through RK Fields Charitable 2022, LLC, along with additional direct and indirect holdings through other entities and his spouse.
ReposiTrak, Inc. (TRAK) CEO and 10% owner Randall K. Fields reported multiple stock movements involving company shares. On 11/24/2025, 200,000 shares of common stock were transferred out of his direct ownership and 200,000 shares were received by RK Fields Charitable 2022, LLC as a gift at a reported price of $0. The same day, that charitable entity sold 1,000 shares at a weighted average price of $13.1169, followed by an additional sale of 6,500 shares on 11/25/2025 at a weighted average price of $13.1791.
The sales were executed automatically under a Rule 10b5-1 trading plan established to help meet charitable commitments. Following these transactions, Fields reported continued indirect holdings through several entities, including RK Fields Charitable 2022, LLC, Riverview Financial Corp., his spouse, and Fields Management, Inc., as well as direct ownership of ReposiTrak common stock.